© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Making an investment decision in the stock market involves a certain amount of risk, so it's important to thoroughly review a company's stock before making any decisions. Stock float, number of short positions and outstanding shares are among the many factors an investor should take into account.
About N/A of shares are held by financial institutions. STATE OF WISCONSIN INVESTMENT BOARD is the top corporate investor, holding 0 shares valued at -. A 0% stake in ImmunoGen, Inc. is owned by the company. UBS ASSET MANAGEMENT AMERICAS INC owns 0 shares valued at -, which translates its holding of 0% of the stake in the company.
Among the IMGN insiders holding of N/A of the stake in company, ENYEDY MARK J, CHIEF EXECUTIVE OFFICER, holds the largest shares of 584.4K. GREGORY RICHARD J., Executive VP & CSO, is the second largest IMGN insider with ownership of 236.06K shares. JUNIUS DANIEL M, director, stands third with possession of 184.99K shares of that stake.
A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own IMGN shares is N/A, representing N/A of the company's common stock.
STATE OF WISCONSIN INVESTMENT BOARD, in the last quarter, reduced its stake in IMGN by -100% restricting it's holding to 0 shares of worth nearly -. UBS ASSET MANAGEMENT AMERICAS INC also lessened -100% of the IMGN shares from its portfolio, reducing its holding to 0 shares of worth -. HSBC HOLDINGS PLC also shunned IMGN shares holding by -100% last quarter which brought its holding to 0 shares worth -.
As per its latest 13F filing, MATHER GROUP, LLC. increased its stake in IMGN by 100% in the last quarter. The institutional holder raised its holding to 62 shares having worth more than $1.84K. MARSHALL WACE, LLP also added 100% more shares of IMGN to its portfolio, raising its holding to 1.19 million shares of worth $35.20M. VANGUARD GROUP INC also increased its IMGN shares holding by 4.02% which brought its holding to 25.47 million shares worth $755.10M.
The insider with the most stakes in IMGN is Enyedy Mark J , CHIEF EXECUTIVE OFFICER at the company. Additionally, IMGN stock is highly held by Executive VP & CSO Gregory Richard J. and director JUNIUS DANIEL M among others.
Company executives, directors, and other insiders own N/A percent of ImmunoGen, Inc.'s stock. Within the last six months, there have been 0 transaction(s) in which IMGN insiders have sold stock, totaling 0 shares. Insiders that have sold shares include LENTINI RENEE, COEN STACY ANN, and ENYEDY MARK J.
There have been 0 transaction(s) during the past 6-months in which ImmunoGen, Inc. insiders have bought stock, totalling 0 shares
Around 0 ImmunoGen, Inc. shares are held by insiders, which represents about N/A of IMGN stock.
IMGN CHIEF EXECUTIVE OFFICER, Enyedy Mark J holds the largest portfolio of the company's shares. IMGN shares owned by Enyedy total nearly 584.4 thousand.
STATE OF WISCONSIN INVESTMENT BOARD is the largest institutional owner in IMGN which holds 0 shares worth - or 0% of the total IMGN shares outstanding followed by UBS ASSET MANAGEMENT AMERICAS INC with ownership of 0 shares representing 0% of the IMGN ownership. HSBC HOLDINGS PLC is the third largest stakeholder with 0 shares or 0% of the ownership worth more than -.
Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the IMGN is concerned, it is a stock which is not optionable.
Number of IMGN shares short is 20.61M. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.
As of today, 279.35M shares of IMGN are outstanding.
Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, IMGN has 247.85M shares in float.
Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for IMGN is null.